# Phase I trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery

> **NIH NIH N01** · NORTHWESTERN UNIVERSITY · 2020 · $206,138

## Abstract

The proposed clinical trial will address whether daily application of endoxifene gel in escalating dose cohorts is tolerable and safe compared to placebo gel.

## Key facts

- **NIH application ID:** 10173569
- **Project number:** 261201200035I-P00003-26100014-1
- **Recipient organization:** NORTHWESTERN UNIVERSITY
- **Principal Investigator:** Seema Khan
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $206,138
- **Award type:** —
- **Project period:** 2017-09-15 → 2021-09-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10173569

## Citation

> US National Institutes of Health, RePORTER application 10173569, Phase I trial of Endoxifen Gel Versus Placebo Gel in Women Undergoing Breast Surgery (261201200035I-P00003-26100014-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10173569. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*